Redpoint Investment Management Pty LTD Bristol Myers Squibb CO Transaction History
Redpoint Investment Management Pty LTD
- $684 Million
- Q3 2022
A detailed history of Redpoint Investment Management Pty LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 47,295 shares of BMY stock, worth $2.69 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
47,295
Previous 55,741
15.15%
Holding current value
$2.69 Million
Previous $4.29 Million
21.67%
% of portfolio
0.49%
Previous 0.51%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.7 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.01 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.28 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.43 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.47 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...